Objective: This study analyzes differences between HIV statistics in Hispanic American countries that have passed UHC legislation versus those that have not passed UHC legislation. In 2017, 0.4% of the population of Latin America and 1.2% of the population of the Caribbean was living with Human Immunodeficiency Virus (HIV).1 Because of these high rates of HIV in Hispanic America, as well as the lethality of HIV if untreated, HIV statistics and treatment outcomes in Hispanic America are of great concern. Relationships between HIV statistics and Universal Health Coverage (UHC) legislation could serve as a metric for UHC performance in Hispanic American countries. Methods: The HIV statistics analyzed are HIV prevalence, HIV incidence, number of acquired immune deficiency syndrome (AIDS) related deaths, percent of people with HIV receiving anti-retroviral therapy (ART), 12-month retention on ART, mother-to-child HIV transmission rate, percent of people living with HIV whose deaths were averted due to ART, and percent of people living with HIV who have suppressed viral loads. HIV/AIDS data for this study was found from UNAIDS,1 and the UHC legislation data was found from WHO’s Global Health Observatory.2 Data was analyzed with independent t-tests to compare HIV statistics in countries that have passed UHC legislation versus those that have not passed UHC legislation. Results: Countries that have passed UHC legislation have significantly higher prevalence (p = .04) and incidence (p = .02) of HIV than countries that have not passed UHC legislation. Countries that have passed UHC legislation have significantly less deaths due to AIDS (p = .03).
Frantz, J. (2020). Universal Health Coverage and HIV in Hispanic America. Wright State University. Dayton, Ohio.